Table 1.
Approval status of the target-specific anticoagulants used in the United States, by indication (as of September 10, 2014)
VTE indicates venous thromboembolism (deep vein thrombosis and/or pulmonary embolism).
* After an initial 5-day treatment with heparin or low-molecular-weight heparin.
